Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006-Reference-Cited by-同舟云学术

Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006

Published:2007-01 Issue:2 Volume:43 Page:238-257
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Liebens Fabienne Patricia,Carly Birgit,Pastijn Ann,Rozenberg Serge

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference115 articles.

1. Common hereditary cancers and implications for primary care;Emery;Lancet,2001

2. Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications;McClain;Genet Med,2005

3. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program;Brose;J Natl Cancer Inst,2002

4. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families;Easton;The Breast Cancer Linkage Consortium. Am J Hum Genet,1993

5. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2;King;Science,2003

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline;Current Oncology;2023-06-30

2. Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2021-02-09

3. Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans;Medicina;2020-10-01

4. The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans;Hereditary Cancer in Clinical Practice;2019-01-03

5. Germline breast cancer susceptibility gene mutations and breast cancer outcomes;BMC Cancer;2018-03-22